World's First iPS Cell-Based Heart Therapy Performed in Osaka
A groundbreaking medical procedure took place in Osaka, Japan, where a heart muscle sheet created from induced pluripotent stem (iPS) cells was successfully transplanted into a heart failure patient. This marks the first time such a therapy has been used in a clinical setting and is covered by insurance. The surgery was performed at Osaka Police Hospital and involved a product called RiHEART, developed by Cuorips Inc. The patient's condition is stable, and they may be discharged within two weeks if recovery proceeds smoothly.13 sourcesSee all sources